country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-187179

Copy Link Print Information

CDK2-IN-62

CDK2-IN-62 is a predicted CDK2 inhibitor. CDK2-IN-62 induces apoptosis in breast cancer cells and reduces their colony-forming ability. CDK2-IN-62 can be used for the research of breast cancer, ovarian cancer and colorectal cancer.

For research use only. We do not sell to patients.

Formula: C₂₇H₂₁N₃O₂S
Molecular Weight:451.54

Storage:

Please store the product under the recommended conditions in the Certificate of Analysis.

CDK2-IN-62 Chemical Structure

Size

Price

Stock

Quantity

Amount: USD 0.00

* Please select Quantity before adding items.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- Description
- IC₅₀ & Target
- In Vitro
Chemical Information
Purity & Documentation
References
Calculators
Help & FAQs
Classifications
Bioz

Biological Activity

Description

IC₅₀ & Target^[1]

human CDK2

All CDK Isoforms :

In Vitro

CDK2-IN-62 (Compound 4e) (48 h) inhibits the viability of MCF-7, A2780cis and HT-29 cells with IC₅₀ values of 9.19, 8.21 and 18.84 μM, respectively; it shows low toxicity to normal CHO epithelial cells^[1].
CDK2-IN-62 (9.19 μM; 48 h) inhibits clonal proliferation of human breast cancer MCF-7 cells^[1].
CDK2-IN-62 (9.19 μM; 36 h) induces apoptosis in MCF-7 human breast cancer cells^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Apoptosis Analysis^[1]

Cell Line:

MCF-7 human breast cancer cells
Concentration:

9.19 μM
Incubation Time:

36 h
Result:

Increased the total percentage of apoptotic MCF-7 cells (early + late apoptosis) to 53.1%, up from 4.22% in control cells; necrotic cells accounted for 18.5% of treated cells.

Cell Proliferation Assay^[1]

Cell Line:

MCF-7 human breast cancer cells
Concentration:

9.19 μM
Incubation Time:

48 h
Result:

Significantly reduced the number of colonies formed by MCF-7 cells compared to the control group.

Chemical Information

Molecular Weight 451.54
Formula C₂₇H₂₁N₃O₂S
SMILES

N#CC1=C(N)OC(C)=C(SC2=CC=CC=C2)C31C(N(CC4=CC=CC=C4)C5=C3C=CC=C5)=O
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation

Handling Instructions (2659 KB)

References

[1]. Jamshidi Z, et al. Multicomponent synthesis of novel spiro-indoline-3,4'-pyran derivatives: in silico and in vitro study. Sci Rep. 2026 Jun 27.
[Content Brief]

Calculators

Molarity Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Dilution Calculator

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

MOQ

Minimum order quantity

100 mg

Get Quote In-stock

Other size

Get Quote

Amount: USD 0.00

Biological Activity
- Description
- IC₅₀ & Target
- In Vitro
Chemical Information
Purity & Documentation
References

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Product Name:
CAS No.:
Species:
Purity:
Quantity:

CDK2-IN-62

All CDK Isoforms

Biological Activity

Chemical Information

Purity & Documentation

References

Calculators

Help & FAQs

CDK2-IN-62 Related Classifications

HY-187179 Related Classifications